SAN DIEGO, April 5, 2022 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide ...
Appointment enhances strategic and financial leadership as the Company advances CMP-002 toward a planned first-in-human Phase 1/2 clinical trial for SYNGAP1-related disorder CAMBRIDGE, Mass., March 24 ...
SAN DIEGO, May 19, 2020 /PRNewswire/ -- Avidity Biosciences (Avidity), a privately-held biopharmaceutical company pioneering Antibody Oligonucleotide Conjugates (AOCs™), announced today the ...
Camp4 Therapeutics Corp (NASDAQ:CAMP) announced the appointment of Michael MacLean as a Class III director, effective April 1. The company’s board of directors also appointed MacLean to its Audit ...
What does this Advisor Specialize in? Find a financial advisor who specializes in the area of expertise you require. It's important to find an advisor who can help you approach your personal and ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
CAMBRIDGE, Mass., March 24, 2026 (GLOBE NEWSWIRE)-- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results